J 2021

Clinically relevant copy-number variants in exome sequencing data of patients with dystonia

ZECH, M., S. BOESCH, M. SKORVANEK, J. NECPAL, J. SVANTNEROVA et. al.

Základní údaje

Originální název

Clinically relevant copy-number variants in exome sequencing data of patients with dystonia

Autoři

ZECH, M. (garant), S. BOESCH, M. SKORVANEK, J. NECPAL, J. SVANTNEROVA, M. WAGNER, Y. DINCER, A. SADR-NABAVI, T. SERRANOVA, Irena REKTOROVÁ (203 Česká republika, domácí), P. HAVRANKOVA (203 Česká republika), S. GANAI, A. MOSEJOVA, I. PRIHODOVA (203 Česká republika), J. SARLAKOVA (203 Česká republika), K. KULCSAROVA, O. ULMANOVA (203 Česká republika), K. BECHYNE, M. OSTROZOVICOVA, V. HAN, J. R. VENTOSA, M. SHARIATI, A. SHOEIBI, S. WEBER, B. MOLLENHAUER, C. TRENKWALDER, R. BERUTTI, T. M. STROM, A. CEBALLOS-BAUMANN, V. MALL, B. HASLINGER, R. JECH (203 Česká republika) a J. WINKELMANN

Vydání

PARKINSONISM & RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2021, 1353-8020

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.402

Kód RIV

RIV/00216224:14110/21:00121363

Organizační jednotka

Lékařská fakulta

UT WoS

000628766400001

Klíčová slova anglicky

Copy-number variant; Dystonia; Read-depth analysis; Diagnostic yield

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 1. 2022 09:40, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Next-generation sequencing is now used on a routine basis for molecular testing but studies on copy-number variant (CNV) detection from next-generation sequencing data are underrepresented. Utilizing an existing whole-exome sequencing (WES) dataset, we sought to investigate the contribution of rare CNVs to the genetic causality of dystonia. Methods: The CNV read-depth analysis tool ExomeDepth was applied to the exome sequences of 953 unrelated patients with dystonia (600 with isolated dystonia and 353 with combined dystonia; 33% with additional neurological involvement). We prioritized rare CNVs that affected known disease genes and/or were known to be associated with defined microdeletion/microduplication syndromes. Pathogenicity assessment of CNVs was based on recently published standards of the American College of Medical Genetics and Genomics and the Clinical Genome Resource. Results: We identified pathogenic or likely pathogenic CNVs in 14 of 953 patients (1.5%). Of the 14 different CNVs, 12 were deletions and 2 were duplications, ranging in predicted size from 124bp to 17 Mb. Within the deletion intervals, BRPF1, CHD8, DJ1, EFTUD2, FGF14, GCH1, PANK2, SGCE, UBE3A, VPS16, WARS2, and WDR45 were determined as the most clinically relevant genes. The duplications involved chromosomal regions 6q21-q22 and 15q11-q13. CNV analysis increased the diagnostic yield in the total cohort from 18.4% to 19.8%, as compared to the assessment of single-nucleotide variants and small insertions and deletions alone. Conclusions: WES-based CNV analysis in dystonia is feasible, increases the diagnostic yield, and should be combined with the assessment of single-nucleotide variants and small insertions and deletions.

Návaznosti

825575, interní kód MU
Název: European Joint Programme on Rare Diseases (Akronym: EJP RD)
Investor: Evropská unie, European Joint Programme on Rare Diseases, Health, demographic change and wellbeing (Societal Challenges)